Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Suliqua 100 units/ml + 50 micrograms/ml solution for injection in a pre-filled pen

Active Ingredient:
insulin glargine , lixisenatide
Company:  
SANOFI See contact details
ATC code: 
A10AE54
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Suliqua- HCP Guide - Important information on dosing

{healthcare_pro_orange} For Healthcare Professionals

GUIDE AND CHECKLIST FOR HEALTHCARE PROFESSIONALS Avoiding medication errors with SULIQUA (insulin glargine 100 units/ml + lixisenatide) — available in 2 pre-filled pens containing different dosage strengths.

{pdf_link}

Suliqua- Patient Guide - Important information on dosing

This card is provided only as a guide to avoid medication errors. Before using Suliqua®, you must be trained on how to use the Suliqua SoloStar® pen by your doctor, nurse or pharmacist, and you must carefully read the patient leaflet and the instructions for use accompanying the pen

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

SANOFI
Company image
Address
Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
Medical Information e-mail
[email protected]
Medical Information Direct Line
+44 (0)800 035 2525
Telephone
+44 (0)118 354 3000